Evidence map›Paper›PMID 21820171›Full record

ArticleBiomaterials2011

Changes of chondrocyte expression profiles in human MSC aggregates in the presence of PEG microspheres and TGF-β3.

Soumya Ravindran, Jacob L Roam, Peter K Nguyen, Thomas M Hering, Donald L Elbert, Audrey McAlinden

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. miR-483 targets SMAD4 to suppress chondrogenic differentiation of human mesenchymal stem cells.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR).Matrix biology : journal of the International Society for Matrix Biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Soumya RavindranDepartment of Orthopaedic Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Jacob L Roam
Peter K Nguyen
Thomas M Hering
Donald L Elbert
Audrey McAlinden
Washington University in St. Louis · USUniversity of Kentucky · US

Funding

LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI SILVA, MATTHEW J · 2009 to 2018
$5.7M
Development of materials to release bioactive lipidsR01HL085364 · NHLBI · WASHINGTON UNIVERSITY · PI ELBERT, DONALD L · 2006 to 2010
$1.8M
Novel Collagen II Alternative Transcripts and Mouse Skeletal DevelopmentR21RR025397 · NCRR · WASHINGTON UNIVERSITY · PI MCALINDEN, AUDREY · 2009 to 2010
$416k
NCRR NIH HHS R21 RR025397NCRR NIH HHS R21RR025397NHLBI NIH HHS R01 HL085364NHLBI NIH HHS R01HL085364NIAMS NIH HHS P30 AR057235NICHD NIH HHS 5R24HD000836NICHD NIH HHS R24 HD000836
6 · The paper itself

Abstract

Biomaterial microparticles are commonly utilized as growth factor delivery vehicles to induce chondrogenic differentiation of mesenchymal stem/stromal cells (MSCs). To address whether the presence of microparticles could themselves affect differentiation of MSCs, a 3D co-aggregate system was developed containing an equal volume of human primary bone marrow-derived MSCs and non-degradable RGD-conjugated poly(ethylene glycol) microspheres (PEG-μs). Following TGF-β3 induction, differences in cell phenotype, gene expression and protein localization patterns were found when compared to MSC aggregate cultures devoid of PEG-μs. An outer fibrous layer always found in differentiated MSC aggregate cultures was not formed in the presence of PEG-μs. Type II collagen protein was synthesized by cells in both culture systems, although increased levels of the long (embryonic) procollagen isoforms were found in MSC/PEG-μs aggregates. Ubiquitous deposition of type I and type X collagen proteins was found in MSC/PEG-μs cultures while the expression patterns of these collagens was restricted to specific areas in MSC aggregates. These findings show that MSCs respond differently to TGF-β3 when in a PEG-μs environment due to effects of cell dilution, altered growth factor diffusion and/or cellular interactions with the microspheres. Although not all of the expression patterns pointed toward improved chondrogenic differentiation in the MSC/PEG-μs cultures, the surprisingly large impact of the microparticles themselves should be considered when designing drug delivery/scaffold strategies.

Indexed as

Gene Expression ProfilingActinsCell DifferentiationCells, CulturedChondrocytesCollagen Type IICollagen Type XHumansImmunohistochemistryMesenchymal Stem CellsMicrospheresOligopeptidesPolyethylene GlycolsProteoglycansReal-Time Polymerase Chain ReactionTransforming Growth Factor beta3ACTA2 protein, humanActinsarginyl-glycyl-aspartic acidCollagen Type IICollagen Type XOligopeptidesPolyethylene GlycolsProteoglycansTransforming Growth Factor beta3

Identifiers

PMID21820171
PMCPMC3176960
OpenAlexW1996602188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.